Let’s talk #drugprices! @US_FDA needs $ + staff to approve #biosimilars in the pipeline, create competition. #BsUFA
https://t.co/LNrre6StnQ
Let’s talk #drugprices! @US_FDA needs $ + staff to approve #biosimilars in the pipeline, create competition. #BsUFA
https://t.co/LNrre6StnQ